Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and a common cause of cancer-related death.Better understanding of the molecular mechanisms, pathogenesis, and treatment of NSCLC can help improve patient outcomes.Significant progress has been made in the Mug treatment of NSCLC, and immunotherapy can prolong patient survival
Abstract Although culture-based identification of bacteria is the gold-standard for the diagnosis of infectious diseases, it is time consuming.Recent advances in Dildos molecular diagnostics and microfluidic technologies have opened up new avenues for rapid detection of bacteria.Here, we describe a centrifugal-microfluidic chip for the detection of
Kun-Chun Chiang,1 Sheng-Teng Huang,2 Ren-Chin Wu,3 Shih-Chiang Huang,3 Ta-Sen Yeh,4 Ming-Huang Chen,5 Jun-Te Hsu,4 Li-Wei Chen,6 Sheng-Fong Kuo,7 Ho-Yen Chueh,8 Horng-Heng Juang,9 Shuen-Iu Hung,10 Chun-Nan Yeh,4 Jong-Hwei S Pang11,12 1General Surgery Department, Chang Gung Memorial Hospital, Chang Gung University, Keelung, Taiwan, ROC; 2Department
LncRNAs have been recently implicated in the epigenetic control of muscle differentiation and their functional characterization has traditionally STYLING MOUSSE relied upon in vitro models of myogenic differentiation.However, the use of experimental paradigms to specifically target lncRNAs expression in muscle stem cells (MuSCs), also known as sate